Literature DB >> 19378024

Toll-like receptors and rheumatoid arthritis.

Fabia Brentano1, Diego Kyburz, Steffen Gay.   

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease that ultimately leads to the progressive destruction of cartilage and bone in numerous joints. There is mounting evidence for an important function of innate immunity in the pathogenesis of RA. Activation of cells by microbial components and also by endogenous molecules via Toll-like receptor (TLR) results in the production of a variety of proinflammatory cytokines, chemokines, and destructive enzymes, some of which can characteristically be found in RA.By immunohistochemistry we found elevated TLR2, 3, and 4 expressions in the rheumatoid synovium. In the synovial lining layer and at sites of invasion into cartilage, RA synovial fibroblasts (RASF) are the major cells expressing TLR2, 3, and 4. Stimulation of cultured RASF in vitro with the TLR2 ligand bacterial lipoprotein (bLP), the TLR3 ligand poly(I-C), and the TLR4 ligand LPS was shown to upregulate IL-6 as well as matrix metalloproteinases (MMPs) 1 and 3. These results suggest an important role for TLR2, 3, and 4 in the activation of synovial fibroblasts in RA leading to chronic inflammation and joint destruction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19378024     DOI: 10.1007/978-1-59745-541-1_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

1.  IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).

Authors:  Zhihong Chen; Lingkai Su; Qingan Xu; Jenny Katz; Suzanne M Michalek; Mingwen Fan; Xu Feng; Ping Zhang
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

2.  TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice.

Authors:  Ningwen Tai; F Susan Wong; Li Wen
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

3.  Increased levels of matrix metalloproteinase-3 in the sera and synovial fluids of patients with pustulotic arthro-osteitis associated with palmoplantar pustulosis: report of 2 cases.

Authors:  Toshiyuki Yamamoto
Journal:  Rheumatol Int       Date:  2012-03-24       Impact factor: 2.631

Review 4.  Toll-like receptors and B cells: functions and mechanisms.

Authors:  Claire M Buchta; Gail A Bishop
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

5.  Norisoboldine inhibits the production of pro-inflammatory cytokines in lipopolysaccharide-stimulated RAW 264.7 cells by down-regulating the activation of MAPKs but not NF-κB.

Authors:  Yubin Luo; Mei Liu; Yue Dai; Xiujuan Yao; Yufeng Xia; Guixin Chou; Zhengtao Wang
Journal:  Inflammation       Date:  2010-12       Impact factor: 4.092

Review 6.  TLRs, future potential therapeutic targets for RA.

Authors:  Hatem A Elshabrawy; Abdul E Essani; Zoltán Szekanecz; David A Fox; Shiva Shahrara
Journal:  Autoimmun Rev       Date:  2016-12-15       Impact factor: 9.754

7.  Pro-inflammatory action of Candida albicans DNA in zymosan-induced arthritis.

Authors:  Petya Dimitrova; Svetla Danova; Nina Ivanovska
Journal:  Inflamm Res       Date:  2012-03-04       Impact factor: 4.575

8.  Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions.

Authors:  Agnieszka Jezierska; Irina A Kolosova; Alexander D Verin
Journal:  Curr Signal Transduct Ther       Date:  2011

9.  TXNDC5 synergizes with HSC70 to exacerbate the inflammatory phenotype of synovial fibroblasts in rheumatoid arthritis through NF-κB signaling.

Authors:  Lin Wang; Hongyan Dong; Guanhua Song; Rui Zhang; Jihong Pan; Jinxiang Han
Journal:  Cell Mol Immunol       Date:  2017-06-26       Impact factor: 11.530

Review 10.  Alternatively activated macrophages in infection and autoimmunity.

Authors:  Delisa Fairweather; Daniela Cihakova
Journal:  J Autoimmun       Date:  2009-10-12       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.